Moxetumomab pasudotox-tdfk Intravenous and Procainamide
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Procainamide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: procainamide
Brand name: Pronestyl, Procan SR, Pronestyl-SR, Procanbid
Synonyms: Procainamide (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Procainamide capsules
- Moxetumomab pasudotox-tdfk Intravenous-Procainamide Hydrochloride
- Moxetumomab pasudotox-tdfk Intravenous-Procainamide injection
- Moxetumomab pasudotox-tdfk Intravenous-Procainamide Intravenous
- Moxetumomab pasudotox-tdfk Intravenous-Procaine penicillin
- Moxetumomab pasudotox-tdfk Intravenous-ProcalAmine
- Procainamide-Moxifloxacin
- Procainamide-Moxifloxacin (Systemic)
- Procainamide-Moxifloxacin Hydrochloride
- Procainamide-Moxifloxacin Injection
- Procainamide-Moxifloxacin Intravenous
- Procainamide-Moxifloxacin Tablets